U.S. Retrospective Collaborative Study of Melanoma Patients receiving Immune Checkpoint Therapy; "Real World Study"
Research Grant
Administered By
Duke Cancer Institute
Awarded By
Bristol-Myers Squibb Company
Start Date
August 5, 2024
End Date
August 4, 2027
Administered By
Duke Cancer Institute
Awarded By
Bristol-Myers Squibb Company
Start Date
August 5, 2024
End Date
August 4, 2027